Showing results (141-150 of 222) with videos related to

Sort By:
Pageof 23
Oncotarget|April 14, 2017
Human a-L-fucosidase-1 attenuates the invasive properties of thyroid cancerGiancarlo Vecchio, Alessia Parascandolo, Chiara Allocca, et al.
Proteome Science|June 10, 2011
Evaluation of formalin-fixed paraffin-embedded tissues in the proteomic analysis of parathyroid glandsElena Donadio, Laura Giusti, Filomena Cetani, et al.
The Journal of Clinical Endocrinology and Metabolism|January 23, 2021
Genetic Profiling of Orbital Fibroblasts from Patients with Graves' OrbitopathyGiovanna Rotondo Dottore, Ilaria Bucci, Giulia Lanzolla, et al.
The Journal of Clinical Endocrinology and Metabolism|March 11, 2011
TWIST1 plays a pleiotropic role in determining the anaplastic thyroid cancer phenotypePaolo Salerno, Ginesa Garcia-Rostan, Sara Piccinin, et al.
Clinical Endocrinology|September 13, 2008
Thiazolidinediones and antiblastics in primary human anaplastic thyroid cancer cellsAlessandro Antonelli, Silvia Martina Ferrari, Poupak Fallahi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2007
WWOX expression in different histologic types and subtypes of non-small cell lung cancerValentina Donati, Gabriella Fontanini, Matteo Dell'Omodarme, et al.
The Journal of Clinical Endocrinology and Metabolism|May 27, 2020
Thyroglobulin Changes are Highly Dependent on TSH in Low-risk DTC Patients not Treated with RadioiodineAntonio Matrone, Alessio Faranda, Francesco Latrofa, et al.
Human Pathology|January 26, 2005
Applications of tissue microarray technology in immunohistochemistry: a study on c-kit expression in small cell lung cancerValentina Donati, Pinuccia Faviana, Matteo Dell'omodarme, et al.
Frontiers in Oncology|April 25, 2022
Core Needle Biopsy Can Early and Precisely Identify Large Thyroid MassesAntonio Matrone, Luigi De Napoli, Liborio Torregrossa, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|September 27, 2019
DELAYED 131-I FIRST TREATMENT AFTER SURGERY HAS NO IMPACT ON THE MEDIAN TERM OUTCOME OF PATIENTS WITH INTERMEDIATE RISK DIFFERENTIATED THYROID CANCERAntonio Matrone, Carla Gambale, Liborio Torregrossa, et al.
Pageof 23